MetaADEDB 2.0 @ LMMD
Daptomycin
(DOAKLVKFURWEDJ-UHFFFAOYSA-N)
Structure
SMILES
NCCCC1NC(=O)CNC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(Cc2c[nH]c3c2cccc3)NC(=O)CCCCCCCCC)CC(=O)N)CC(=O)O)C(C)OC(=O)C(NC(=O)C(NC(=O)C(NC(=O)CNC(=O)C(NC(=O)C(NC(=O)C(NC1=O)CC(=O)O)C)CC(=O)O)CO)C(CC(=O)O)C)CC(=O)c1ccccc1N
Molecular Formula:
C72H101N17O26
Molecular Weight:
1620.670
Log P:
0.8828
Hydrogen Bond Acceptor:
42
Hydrogen Bond Donor:
22
TPSA:
702.02
CAS Number(s):
103060-53-3
Synonym(s)
1.
Daptomycin
2.
Cubicin
3.
Daptomycin, 9-L beta-Aspartic Acid
4.
Deptomycin
5.
LY-146032
6.
Daptomycin, 9 L beta Aspartic Acid
7.
LY 146032
8.
LY146032
External Link(s)
MeSHD017576
PubChem Compound16129688
CHEMBLCHEMBL404822
Therapeutic Target DatabaseD05HPI
Adverse Drug Event(s)
NameNumber of ReportsReference(s)Data Source
1Abdominal PainSIDER
2Abdominal bloatingSIDER
3Alanine Aminotransferase IncreasedSIDER
4Anaphylactic shockSIDER
5AngioedemaSIDER
6AnxietySIDER
7ArthralgiaSIDER
8Aspartate Aminotransferase IncreasedSIDER
9AstheniaSIDER
10Atrial FibrillationSIDER
11Atrial FlutterSIDER
12Back PainSIDER
13Blood alkaline phosphatase increasedSIDER
14Blood and lymphatic system disordersSIDER
15Blood creatine phosphokinase increasedSIDER
16Blood creatinine increasedSIDER
17Blood lactate dehydrogenase increasedSIDER
18Blood phosphorus increasedSIDER
19Cardiac ArrestSIDER
20CellulitisSIDER
21Chest PainSIDER
22ChillsSIDER
23CholangitisSIDER
24ConstipationSIDER
25Creatine Phosphokinase IncreasedSIDER
26DermatitisSIDER
27DiscomfortSIDER
28DizzinessSIDER
29DysgeusiaSIDER
30DyspepsiaSIDER
31Ear and labyrinth disordersSIDER
32EczemaSIDER
33Electrolyte imbalanceSIDER
34EosinophiliaSIDER
35Eosinophilic PneumoniaSIDER
36Epigastric discomfortSIDER
37Erythema MultiformeSIDER
38ErythemaSIDER
39Eye irritationSIDER
40FatigueSIDER
41Feeling abnormalSIDER
42Feeling jitterySIDER
43FlatulenceSIDER
44FlushingSIDER
45Gastrointestinal PainSIDER
46GlossitisSIDER
47HeadacheSIDER
48HypersensitivitySIDER
49HypotensionSIDER
50InfectionSIDER
51InfestationSIDER
52Infusion site reactionSIDER
53Injection Site ReactionSIDER
54Injection site erythemaSIDER
55Intestinal infarctionSIDER
56Lactic dehydrogenase activity increasedSIDER
57LeukocytosisSIDER
58LymphadenopathySIDER
59MalnutritionSIDER
60MediastinitisSIDER
61Miliaria RubraSIDER
62MiliariaSIDER
63MonoparesisSIDER
64Musculoskeletal discomfortSIDER
65MyalgiaSIDER
66MyopathySIDER
67MyositisSIDER
68NauseaSIDER
69NervousnessSIDER
70Oral candidiasisSIDER
71Oropharyngeal discomfortSIDER
72Oropharyngeal painSIDER
73Oropharyngeal swellingSIDER
74OsteomyelitisSIDER
75PainSIDER
76Pharyngolaryngeal PainSIDER
77PneumoniaSIDER
78Protein urine presentSIDER
79ProteinuriaSIDER
80PruritusSIDER
81Pulmonary EosinophiliaSIDER
82RhabdomyolysisSIDER
83SepsisSIDER
84Serum bicarbonate increasedSIDER
85ShockSIDER
86Stevens-Johnson SyndromeSIDER
87StomatitisSIDER
88Supraventricular tachycardiaSIDER
89SyncopeSIDER
90TachycardiaSIDER
91Taste DisordersSIDER
92ThrombocytopeniaSIDER
93ThrombocytosisSIDER
94TinnitusSIDER
95Transaminases increasedSIDER
96TremorSIDER
97Urinary tract infection fungalSIDER
98Urinary tract infectionSIDER
99UrticariaSIDER
100VertigoSIDER
101Vesiculobullous rashSIDER
102VomitingSIDER
103Vulvovaginal mycotic infectionSIDER
104WheezingSIDER
105jaundiceSIDER
106nervous system disorderSIDER
Powered by :

Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120239

Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.